Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy.

Allergy · 2025 · PMC11891431 · PMID 39520181

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

26 The improvement in symptoms and medication consumption was highly significant and achieved a difference of 40% compared to placebo after 7 months of treatment, with the improvement in the medication score being even more pronounced than that in symptoms.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.